These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 32635771)

  • 1. Epithelial dysfunction, respiratory infections and asthma: the importance of immunomodulation. A focus on OM-85.
    Cardinale F; Lombardi E; Rossi O; Bagnasco D; Bellocchi A; Menzella F
    Expert Rev Respir Med; 2020 Oct; 14(10):1019-1026. PubMed ID: 32635771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoactive preparations and regulatory responses in the respiratory tract: potential for clinical application in chronic inflammatory airway diseases.
    Feleszko W; Rossi GA; Krenke R; Canonica GW; Van Gerven L; Kalyuzhin O
    Expert Rev Respir Med; 2020 Jun; 14(6):603-619. PubMed ID: 32250709
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical and Immunological Benefits of OM-85 Bacterial Lysate in Patients with Allergic Rhinitis, Asthma, and COPD and Recurrent Respiratory Infections.
    Koatz AM; Coe NA; Cicerán A; Alter AJ
    Lung; 2016 Aug; 194(4):687-97. PubMed ID: 27117798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventive effects of prenatal administration of OM-85/BV on asthma and respiratory infection risk in the offspring: A review of animal models.
    Rahbek-Hansen SH; Mikkelsen M; Stokholm J; Bønnelykke K; Chawes BL; Brustad N
    Pediatr Allergy Immunol; 2024 Jun; 35(6):e14184. PubMed ID: 38924159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A critical analysis of the effect of OM-85 for the prevention of recurrent respiratory tract infections or wheezing/asthma from systematic reviews with meta-analysis.
    Castro-Rodriguez JA; Turi KN; Forno E
    Pediatr Allergy Immunol; 2024 Jul; 35(7):e14186. PubMed ID: 39016384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacterial lysate add-on therapy to reduce exacerbations in severe asthma: A double-blind placebo-controlled trial.
    de Boer GM; Braunstahl GJ; van der Ploeg EK; van Zelst CM; van Bruggen A; Epping G; van Nimwegen M; Verhoeven G; Birnie E; Boxma-de Klerk BM; de Bruijn MJW; Stadhouders R; Hendriks RW; Tramper-Stranders GA
    Clin Exp Allergy; 2021 Sep; 51(9):1172-1184. PubMed ID: 34289183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of OM-85 Given during Two Consecutive Years to Children with a History of Recurrent Respiratory Tract Infections: A Retrospective Study.
    Esposito S; Bianchini S; Polinori I; Principi N
    Int J Environ Res Public Health; 2019 Mar; 16(6):. PubMed ID: 30934539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunopathogenesis of polymicrobial otitis media.
    Bakaletz LO
    J Leukoc Biol; 2010 Feb; 87(2):213-22. PubMed ID: 19843575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonspecific immunomodulators for recurrent respiratory tract infections, wheezing and asthma in children: a systematic review of mechanistic and clinical evidence.
    Esposito S; Soto-Martinez ME; Feleszko W; Jones MH; Shen KL; Schaad UB
    Curr Opin Allergy Clin Immunol; 2018 Jun; 18(3):198-209. PubMed ID: 29561355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Influence of OM-85 BV on hBD-1 and immunoglobulin in children with asthma and recurrent respiratory tract infection].
    Liao JY; Zhang T
    Zhongguo Dang Dai Er Ke Za Zhi; 2014 May; 16(5):508-12. PubMed ID: 24857002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoregulatory and immunostimulatory responses of bacterial lysates in respiratory infections and asthma.
    Kearney SC; Dziekiewicz M; Feleszko W
    Ann Allergy Asthma Immunol; 2015 May; 114(5):364-9. PubMed ID: 25752734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacterial lysate in the prevention of acute exacerbation of COPD and in respiratory recurrent infections.
    Braido F; Tarantini F; Ghiglione V; Melioli G; Canonica GW
    Int J Chron Obstruct Pulmon Dis; 2007; 2(3):335-45. PubMed ID: 18229572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Immunotherapeutic Role of Bacterial Lysates in a Mouse Model of Asthma.
    Liu C; Huang R; Yao R; Yang A
    Lung; 2017 Oct; 195(5):563-569. PubMed ID: 28474108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of a mixed bacterial lysate (OM-85 BV) on the immunogenicity, safety and tolerability of inactivated influenza vaccine in children with recurrent respiratory tract infection.
    Esposito S; Marchisio P; Prada E; Daleno C; Porretti L; Carsetti R; Bosco A; Ierardi V; Scala A; Principi N
    Vaccine; 2014 May; 32(22):2546-52. PubMed ID: 24681270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical experience with OM-85 BV in upper and lower respiratory tract infections.
    Derenne JP; Delclaux B
    Respiration; 1992; 59 Suppl 3():28-31. PubMed ID: 1439237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can bacterial lysates be useful in prevention of viral respiratory infections in childhood? The results of experimental OM-85 studies.
    Ballarini S; Ardusso L; Ortega Martell JA; Sacco O; Feleszko W; Rossi GA
    Front Pediatr; 2022; 10():1051079. PubMed ID: 36479289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The bacterial extract OM-85 BV protects mice against influenza and Salmonella infection.
    Bessler WG; Vor dem Esche U; Masihi N
    Int Immunopharmacol; 2010 Sep; 10(9):1086-90. PubMed ID: 20601184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viral infections in asthma and COPD.
    Matsumoto K; Inoue H
    Respir Investig; 2014 Mar; 52(2):92-100. PubMed ID: 24636264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunity-targeted approaches to the management of chronic and recurrent upper respiratory tract disorders in children.
    Feleszko W; Marengo R; Vieira AS; Ratajczak K; Mayorga Butrón JL
    Clin Otolaryngol; 2019 Jul; 44(4):502-510. PubMed ID: 30920131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expert consensus on the role of OM-85 in the management of recurrent respiratory infections: A Delphi study.
    Esposito S; Cassano M; Cutrera R; Menzella F; Varricchio A; Uberti M
    Hum Vaccin Immunother; 2022 Nov; 18(6):2106720. PubMed ID: 35985019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.